home / lobbying

lobbying_activities

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

214 rows where filing_period = "third_quarter", filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: filing_type, income_amount, is_termination, received_date (date)

issue_code 1

  • PHA · 214 ✖

filing_year 1

  • 2012 · 214 ✖

filing_period 1

  • third_quarter · 214 ✖
id filing_uuid filing_type registrant_name registrant_id client_name filing_year ▲ filing_period issue_code specific_issues government_entities income_amount expense_amount is_no_activity is_termination received_date
1291645 PRIME THERAPEUTICS f6be8340-5748-4a98-935d-99425113ff0b Q3 PRIME THERAPEUTICS 400339576 PRIME THERAPEUTICS 2012 third_quarter PHA Specialty pharmacy facility opening H.R. 4215: Medicare Pharmacy Transparency and Fair Auditing Act H.R. 1971: Pharmacy Competition and Consumer Choice Act of 2011 S. 1058: Pharmacy Competition and Consumer Choice Act of 2011 HOUSE OF REPRESENTATIVES,SENATE   170000 0 0 2012-07-24T15:11:47.357000-04:00
1294140 AMYLIN PHARMACEUTICALS 24c329ad-00da-43d9-8eb4-c8b9777c97d6 3T AMYLIN PHARMACEUTICALS 308536 AMYLIN PHARMACEUTICALS 2012 third_quarter PHA Perscription Drug User Fee Act Reauthorization FDA funding and agency effectiveness Drug importation issues Safeguarding America's Pharmaceuticals Act of 2011- H.R. 3026 HOUSE OF REPRESENTATIVES,SENATE   170000 0 1 2012-09-19T14:47:16.540000-04:00
1294748 CYBER SECURITY RESEARCH CONSULTANTS, LLC 93479c6f-5b6d-473d-b769-f8e86345d6b7 Q3 CYBER SECURITY RESEARCH CONSULTANTS, LLC 91694 PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION 2012 third_quarter PHA Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug reimportation from Canada Monitoring FDA Reauthorization Act HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-01T11:38:38.777000-04:00
1295089 LONG TERM CARE PHARMACY ALLIANCE 1adcf7e2-fbc5-4d46-8368-a7135db2065a Q3 LONG TERM CARE PHARMACY ALLIANCE 400309443 LONG TERM CARE PHARMACY ALLIANCE 2012 third_quarter PHA Medicare Part D Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   201000 0 0 2012-10-03T09:35:23.533000-04:00
1295147 AMERICAN COLLEGE OF CLINICAL PHARMACY 8ee1d045-b7b2-479a-a8a7-ec8038ded7c7 Q3 AMERICAN COLLEGE OF CLINICAL PHARMACY 57258 AMERICAN COLLEGE OF CLINICAL PHARMACY 2012 third_quarter PHA Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   61700 0 0 2012-10-03T11:38:48.013000-04:00
1295391 GRIZZLE COMPANY a67913ed-5ef6-456e-819d-2467c0d5d390 Q3 GRIZZLE COMPANY 16987 KENTUCKYONE HEALTH (FORMERLY JEWISH HOSPITAL HEALTH CARE SERVICES) 2012 third_quarter PHA S.3187, The Food and Drug Administration Safety and Innovation Act (FDASIA): Support provision to give FDA enhanced authority to address drug shortages. Proposed changes to the 340B hospital drug program. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-04T14:04:12.270000-04:00
1295546 PARRY, ROMANI, DECONCINI & SYMMS 3f79de6a-bc6a-4cc4-83d6-6dab786f391c Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 BRAIDWOOD MANAGEMENT, INC. 2012 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T13:14:14.943000-04:00
1295553 SHELTER ROCK STRATEGIES, LLC 43599881-3884-4449-af27-3a30a6df1b57 Q3 SHELTER ROCK STRATEGIES, LLC 400772326 NEW YORK MEDICAL COLLEGE 2012 third_quarter PHA BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aide the client's proposal.       0 0 2012-10-05T13:20:16.437000-04:00
1295558 PARRY, ROMANI, DECONCINI & SYMMS 88c9c96b-fbd1-48d7-933a-152ef81527bd Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 DIAMONDBACK DRUGS 2012 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. HOUSE OF REPRESENTATIVES,SENATE 6000   0 0 2012-10-05T13:35:19.340000-04:00
1295579 PARRY, ROMANI, DECONCINI & SYMMS 508810e1-0f7b-494c-afef-7241dc4e60f0 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 VETERINARY PHARMACIES OF AMERICA, INC. 2012 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:39:33.297000-04:00
1295590 PARRY, ROMANI, DECONCINI & SYMMS 2f46c21f-df05-402f-b105-0ba48de4a478 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WEDGEWOOD VILLAGE PHARMACY, INC. 2012 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:45:38.743000-04:00
1295604 PARRY, ROMANI, DECONCINI & SYMMS 1488395d-1238-473b-9275-c49f2224b83a Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 WOMEN'S INTERNATIONAL PHARMACY, INC. 2012 third_quarter PHA Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. HOUSE OF REPRESENTATIVES,SENATE 11250   0 0 2012-10-05T14:53:44.530000-04:00
1295659 AMERICAN AMBULANCE ASSOCIATION 93fc65cc-c81a-44f3-b39e-e623a5bc7a62 Q3 AMERICAN AMBULANCE ASSOCIATION 56018 AMERICAN AMBULANCE ASSOCIATION 2012 third_quarter PHA Supported efforts to address the drug shortage issue in the Food and Drug Administration Safety and Innovation Act (S. 3187) as it pertains to emergency medical service providers. Centers For Medicare and Medicaid Services (CMS),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE,Veterans Affairs, Dept of (VA)   295000 0 0 2012-10-06T19:56:19.673000-04:00
1295731 UNIVERSITY OF IOWA 8598c359-ca70-4cac-9da3-4c906139fc9a Q3 UNIVERSITY OF IOWA 49191 UNIVERSITY OF IOWA 2012 third_quarter PHA Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research FDA User Fee Bill Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT)   88684 0 0 2012-10-08T10:26:43.090000-04:00
1295815 HOLLAND & KNIGHT LLP 8af6d82a-414a-462e-aad9-90e8d8781687 Q3 HOLLAND & KNIGHT LLP 18466 SAFECOR HEALTH, LLC 2012 third_quarter PHA Drug supply chain provisions in federal legislation; specifically S.3187, The Food & Drug Administration Safety & Innovation Act and H.R. 5651, The Food & Drug Administration Reform Act of 2012. Advocated for provisions recognizing the role of drug repackagers and against provisions to make certain hydrocodone products schedule 2 controlled substances. HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-08T14:03:35.477000-04:00
1295914 INJURED WORKERS PHARMACY 7da1c3b9-ce9d-4a84-a61d-d0dbeb7b6ff0 Q3 INJURED WORKERS PHARMACY 400765309 INJURED WORKERS PHARMACY 2012 third_quarter PHA Transparency of Pharmacy Benefit Managers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshoreman and Harbor Workers Amendment Act of 2011 sponsored by Senator Isakson. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-09T09:34:38.413000-04:00
1296148 PARRY, ROMANI, DECONCINI & SYMMS 0bc1dd46-4989-4d05-b8c1-75f794f0c933 Q3 PARRY, ROMANI, DECONCINI & SYMMS 30792 POZEN, INC. 2012 third_quarter PHA To provide incentives for new drug development. No specific bills pending. HOUSE OF REPRESENTATIVES,SENATE 36000   0 0 2012-10-09T15:52:28.043000-04:00
1296213 GREATER NEW YORK HOSPITAL ASSOCIATION 48be7002-207e-4a0e-a8ce-68a264776bba Q3 GREATER NEW YORK HOSPITAL ASSOCIATION 16830 GREATER NEW YORK HOSPITAL ASSOCIATION 2012 third_quarter PHA Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations; The Food and Drug Administration Safety and Innovation Act (S.3187); issues related to unique device identification. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office   210000 0 0 2012-10-10T09:52:07.243000-04:00
1296399 INDEPENDENT PHARMACY COOPERATIVE b0ffd845-45b6-4f54-afd9-0f040a1f2eac Q3 INDEPENDENT PHARMACY COOPERATIVE 313098 INDEPENDENT PHARMACY COOPERATIVE 2012 third_quarter PHA CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. Potential prescription drug track-and-trace legislation. RxTEC National Average Drug Acuisition Cost (NADAC) implementation. Calculation and Process National Average Retail Price (NARP) implementation. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   10000 0 0 2012-10-10T12:36:26.380000-04:00
1296683 CAPITOL HILL CONSULTING GROUP 2d700ed6-38b0-4ec6-bf77-76bdef84a7d0 Q3 CAPITOL HILL CONSULTING GROUP 72053 PURDUE PHARMA LLP 2012 third_quarter PHA Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) HOUSE OF REPRESENTATIVES,SENATE 15750   0 0 2012-10-10T16:37:33.080000-04:00
1296774 GREENBERG TRAURIG, LLP 33c49f5f-27bf-4cf8-80cf-c23064b2f221 Q3 GREENBERG TRAURIG, LLP 16896 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION (NCPA) 2012 third_quarter PHA Health care legislative and regulatory issues affecting independent community pharmacies. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB) 30000   0 0 2012-10-11T08:52:21.290000-04:00
1297166 RED+BLUE STRATEGIES a6e139c3-c408-4743-9cbc-7ef41a846515 Q3 RED+BLUE STRATEGIES 400693064 EXPRESS SCRIPTS INC. 2012 third_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization. Policies related to stopping the diversion of prescription medications in the nation's drug supply chain. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-10-11T15:34:00.973000-04:00
1297234 MERCURY PUBLIC AFFAIRS, LLC af3cfece-449d-4071-b071-21b43f9e88a8 Q3 MERCURY PUBLIC AFFAIRS, LLC 70175 EXPRESS SCRIPTS INC. 2012 third_quarter PHA Prescription drug monitoring. HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-10-11T16:34:29.043000-04:00
1297251 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM be6042cb-af8c-466f-8323-dfbd5cbbb252 Q3 ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 58534 ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 2012 third_quarter PHA H.R. 2674 Supportive of any language that amends section 340B of the Public Health Service Act to revise and expand the drug discount program under that section to improve the provision of discounts on drug purchases for certain safety net providers by expanding 340B discounts to impatient settings. HOUSE OF REPRESENTATIVES,SENATE   114550 0 0 2012-10-11T17:00:39.870000-04:00
1297308 DUTKO WORLDWIDE, LLC 933f9084-40f0-43b0-9963-e2b884207c95 Q3 DUTKO WORLDWIDE, LLC 12868 NEWAYS INTERNATIONAL 2012 third_quarter PHA Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-11T17:27:00.150000-04:00
1297555 STEVE BUYER GROUP a4ba8e66-7862-47b2-886a-90c722469452 3T STEVE BUYER GROUP 400701097 OMNICARE 2012 third_quarter PHA Advocacy in support of S.1560 promoting changes to the Controlled Substance Act providing access to pain medication for nursing.   30000   0 1 2012-10-12T11:09:45.590000-04:00
1297826 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 93340bfd-9ef9-4259-a090-915515e0b886 Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 NOVO NORDISK 2012 third_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions; S.3187 FDA Safety and Innovation Act (PDUFA V); H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-10-12T14:16:17.543000-04:00
1297833 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 1e7cedf7-292f-454e-a82f-1d6de6676cf7 Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 GENENTECH 2012 third_quarter PHA Monitor Drug Safety and pedigree legislation. Monitor legislation and oversight on compounding pharmacies. Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-10-12T14:22:21.160000-04:00
1298211 HEARTLAND SOLUTIONS GROUP, INC. 9d991209-6ba2-4a4f-bfcb-dc6947cca800 Q3 HEARTLAND SOLUTIONS GROUP, INC. 312133 ZEBRA TECHNOLOGIES CORPORATION 2012 third_quarter PHA Any and all issues related to barcode, secure identification and real-time location systems. HOUSE OF REPRESENTATIVES,SENATE 41250   0 0 2012-10-14T12:21:29.757000-04:00
1298709 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS eda75f89-94c5-4e02-8594-2349159f58b8 Q3 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 1672 AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS 2012 third_quarter PHA the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation (H.R. 5651/S. 3187) Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE   24599 0 0 2012-10-15T11:55:22.777000-04:00
1299014 DENNY MILLER ASSOCIATES d15869e2-bfcd-4dfa-8a89-eab28aa0fa78 Q3 DENNY MILLER ASSOCIATES 25328 CELL THERAPEUTICS 2012 third_quarter PHA European Union approval of US cancer drugs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-15T13:55:42.557000-04:00
1299361 UPS (UNITED PARCEL SERVICE) 9039e44d-58d9-4edd-a18d-a60f791fce72 Q3 UPS (UNITED PARCEL SERVICE) 39223 UPS (UNITED PARCEL SERVICE) 2012 third_quarter PHA - HR 2405 / S.1855 Healthcare Supply Chain Safety - track and trace in the Prescription Drug Users Fee Act Energy, Dept of,Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office   961174 0 0 2012-10-15T15:33:05.367000-04:00
1300423 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 7c12ea80-3ea4-45dc-849c-89963c9e7aab Q3 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 27478 NATIONAL COMMUNITY PHARMACISTS ASSOCIATION 2012 third_quarter PHA S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation; Hydrocodone Issues; S. 3376, PACT Act, S. 2467 and S. 3254 and H.R. 4310, the National Defense Authorization Act for Fiscal Year 2013; S. 3604, Improving Dementia Care Treatment for Older Adults Act of 2012; Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE   300000 0 0 2012-10-16T12:26:47.030000-04:00
1300438 NOVO NORDISK INC. de4b9fbb-3d03-4867-8a33-6baa9f22ee76 Q3 NOVO NORDISK INC. 284790 NOVO NORDISK INC. 2012 third_quarter PHA P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; S.3187 FDA Safety and Innovation Act; H.R. 4274 Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act; H.R. 5973 FY2013 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act (FDA funding); 340B Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office   400000 0 0 2012-10-16T12:29:52.450000-04:00
1300856 TAKEDA PHARMACEUTICALS AMERICA, INC. 4e7e92c9-a03e-4d7f-9edc-2ba6d20d7a14 Q3 TAKEDA PHARMACEUTICALS AMERICA, INC. 57954 TAKEDA PHARMACEUTICALS AMERICA INC 2012 third_quarter PHA PDUFA Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   280000 0 0 2012-10-16T14:32:54.040000-04:00
1301113 VENABLE LLP 703be236-3d80-49bf-8687-bd5469cd590c Q3 VENABLE LLP 39941 ENDO PHARMACEUTICALS INC 2012 third_quarter PHA General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act; H.R. 5651.) The Life Sciences Jobs and Investment Act (S. 1410; H.R. 2632) HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-16T15:20:27.077000-04:00
1301301 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 52dbd21c-44a8-420d-bac2-ceeddf5f3001 Q3 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 30187 AMERISOURCEBERGEN CORPORATION 2012 third_quarter PHA Issues pertaining to Federal Drug Pedigree and Drug Shortages. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-16T16:21:58.423000-04:00
1301375 FOOD MARKETPLACE INC. e2b6f864-7224-4f12-94a3-07ca9c50092f Q3 FOOD MARKETPLACE INC. 15097 FOOD MARKETPLACE INC 2012 third_quarter PHA H.R. 1406 - Fairness to Pet Owners Act of 2011 S. 3376 - Preventing Abuse of Cough Treatments Act Agriculture, Dept of (USDA),Executive Office of the President (EOP),Federal Reserve System,Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Office of Management & Budget (OMB),SENATE,Small Business Administration (SBA),Treasury, Dept of,White House Office   180000 0 0 2012-10-16T16:39:39.347000-04:00
1301441 AMERICAN ACADEMY OF FAMILY PHYSICIANS 612fe9b3-409e-48cf-80f1-f00ffe84cf14 Q3 AMERICAN ACADEMY OF FAMILY PHYSICIANS 1342 AMERICAN ACADEMY OF FAMILY PHYSICIANS 2012 third_quarter PHA No Bill Number, Proposal to create "Special medical use" category of prescription drugs, Should FDA create category of drugs that non physicians like pharmacists could prescribe. No Bill Number, National Priorities and Research Agenda, PCORI should focus research on more common medical conditions first. No Bill, National Drug Control Strategy announcement, New CME for prescribers of opioid analgesics, Support drug control policies which are not burdensome to family physicians. Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),SENATE,White House Office   449038 0 0 2012-10-16T16:53:55.267000-04:00
1301823 WINSTON & STRAWN LLP 753afa1c-b323-46f5-86a5-2a520b466de9 Q3 WINSTON & STRAWN LLP 41682 FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) 2012 third_quarter PHA Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-17T09:36:15.990000-04:00
1301900 BROWN RUDNICK LLP 9e8fa94b-15ba-4b46-86fb-4360cc8561ab Q3 BROWN RUDNICK LLP 287895 HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC 2012 third_quarter PHA H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; S.2997 relating to hydrocodone rescheduling. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-17T09:56:50.247000-04:00
1301914 WINSTON & STRAWN LLP 94797f4f-bbca-4904-853e-eadfda1189ae Q3 WINSTON & STRAWN LLP 41682 WOCKHARDT USA LLC 2012 third_quarter PHA Generic drug issues - federal preemption of state claims; FTC regulation of settlement agreements HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-17T09:59:55.960000-04:00
1302196 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 0e83a118-fdb8-4e94-ab65-81ceadc3fb9e Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 AMERICAN SOCIETY OF HEMATOLOGY 2012 third_quarter PHA Issues related to drug shortages. S.296/HR2245 Preserving Access to Life Saving Medications Act, HR3839 Drug Shortage Prevention Act; S.3187, FDA Safety and Innovation Act. Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 30000   0 0 2012-10-17T10:58:36.760000-04:00
1302354 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9826787a-01c4-45a6-8d0a-4c21db3db811 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 THE HEMOPHILIA ALLIANCE 2012 third_quarter PHA Issues realted to the 340B drug discount program. Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-17T11:18:52.393000-04:00
1302376 FORGE FEDERAL AFFAIRS LLC ab2e1f31-3f6e-4696-aeb6-439da1f6335d Q3 FORGE FEDERAL AFFAIRS LLC 400865535 LILLY USA LLC 2012 third_quarter PHA Issues related to Prescription Drug User Fee Act (PDUFA). HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-17T11:20:59.047000-04:00
1302383 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 620202c3-0809-4fa2-a6e8-df1432ae2eb1 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL HEMOPHILIA FOUNDATION 2012 third_quarter PHA Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. S.3187, FDA Safety and Innovation Act. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 50000   0 0 2012-10-17T11:22:02.093000-04:00
1302400 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. b1a800cb-ab48-498b-b1c5-0188d6d5a1f3 Q3 CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 8511 NATIONAL ASSOCIATION OF EPILEPSY CENTERS 2012 third_quarter PHA Issues related to anti-epileptic drugs. Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE 10000   0 0 2012-10-17T11:24:10.340000-04:00
1302732 OCHSNER CLINIC FOUNDATION 7e46d3d1-f8d9-4626-b1b9-af9751531f2c Q3 OCHSNER CLINIC FOUNDATION 45391 OCHSNER CLINIC FOUNDATION 2012 third_quarter PHA S. 296 A bill to amend the Federal Food, Drug, and Cosmetic Act to provide the Food and Drug Administration with improved capacity to prevent drug shortages. All Provisions. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE   160000 0 0 2012-10-17T12:33:29.197000-04:00
1303165 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 5664dc79-3633-4e4e-8014-d3a3db1d465e Q3 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 TEVA PHARMACUETICALS USA 2012 third_quarter PHA PDUFA re-authorization; NDA-ANDA settlements HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T14:11:18.423000-04:00
1303245 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 84dcda17-6a39-468a-9fdf-60ba75ae0195 Q3 NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 400689052 WOCKHARDT USA LLC 2012 third_quarter PHA PDUFA re-authorization; preemption for generic labeling HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T14:23:53.613000-04:00
1303393 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 1600de5e-e704-4d92-8701-a9c91a6d3ede Q3 MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 24486 ALLIED MEDICAL SUPPLY, INC. 2012 third_quarter PHA Issues affecting resellers of pharmaceutical products HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-10-17T14:36:53.563000-04:00
1303654 RED+BLUE STRATEGIES 9dd8749d-9dd5-4846-a7e7-8c882d0a3fc0 Q3 RED+BLUE STRATEGIES 400693064 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 third_quarter PHA H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. S. 3187 - FDA Safety and Innovation Act - Issues related to supply chain safety, treatment of controlled substances and REMS policies. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-10-17T15:04:34.453000-04:00
1303672 RED+BLUE STRATEGIES f5074845-4add-4100-87d2-25fda3cfaaa5 Q3 RED+BLUE STRATEGIES 400693064 PEW CHARITABLE TRUSTS 2012 third_quarter PHA H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. S. 3187 - The FDA Safety and Innovation Act- specific work on antibiotic innovation, up and down stream supply chain issues, and medical device policies. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Potential language related to Track and Trace provisions regarding downstream supply chain safety being considered by the Senate HELP and House Energy and Commerce Committees. Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T15:08:41.387000-04:00
1303841 WHITMER & WORRALL, LLC d9e779fb-b1d1-431f-8a6e-49e34cf0cbb4 Q3 WHITMER & WORRALL, LLC 292892 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 third_quarter PHA Issues related to monitoring healthcare reform. Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-17T15:27:39.910000-04:00
1304030 MCDERMOTT WILL & SCHULTE LLP 481a29c1-d9e6-4b1b-80f7-c9ad98cf7a9c Q3 MCDERMOTT WILL & SCHULTE LLP 24338 ALLERGAN, INC. 2012 third_quarter PHA Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE 10000   0 0 2012-10-17T15:53:08.413000-04:00
1304291 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 5e4e875c-999a-4d4e-b178-7ef29a1063d8 Q3 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 3457 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 2012 third_quarter PHA S. 3187, Support for the Drug Shortages provisions within the "Food and Drug Administration Safety and Innovation Act." H.R. 6413, support for the "Transitional Care Act of 2012." Contact concerning Food and Drug Administration (FDA) authority to manage drug shortages. Communications to FDA on approval of biosimilars and drug safety. Communications to Health Resources and Services Administration on 340B drug discount program. Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   250000 0 0 2012-10-17T16:56:10.853000-04:00
1304526 POLICY ADVOCATES 1c43a02c-4519-4189-a2fe-68e475054d9d Q3 POLICY ADVOCATES 72018 GLAXOSMITHKLINE 2012 third_quarter PHA PDUFA Medicare Part D HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2012-10-17T18:13:47.537000-04:00
1304637 NEW JERSEY HOSPITAL ASSOCIATION a6f661e2-9c25-4731-bcf3-7e6677626fca Q3 NEW JERSEY HOSPITAL ASSOCIATION 29128 NEW JERSEY HOSPITAL ASSOCIATION 2012 third_quarter PHA Support provisions included in S. 3187, the Food and Drug Administration Safety and Innovation Act, which would help speed safe and effective medical products to patients and maintain our nations role as a leader in biomedical innovation. This legislation will drive timely review of new innovator drugs and medical devices, enhance the safety of the drug supply chain in an increasingly globalized market, increase incentives for the development of new antibiotics, renew mechanisms to ensure that childrens medicines are appropriately tested and labeled, and expedite the development and review of certain drugs for the treatment of serious or life-threatening diseases and conditions. HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2012-10-17T21:10:40.550000-04:00
1304708 POLICY ADVOCATES bbe1ec07-0708-410b-b483-6ca3e60d77dd Q3 POLICY ADVOCATES 72018 PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA 2012 third_quarter PHA Prescription Drug User Fee Act (PDUFA) Drug Importation HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-17T23:25:20.530000-04:00
1304709 THORN RUN PARTNERS aa1aa6d1-014d-446a-bbc7-16229dbd8b1d Q3 THORN RUN PARTNERS 400534596 LONG TERM CARE PHARMACY ALLIANCE 2012 third_quarter PHA S.1560, Nursing Home Resident Pain Relief Act of 2011; issues related to the implementation of the Affordable Care Act (ACA), DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy; issues related to PDUFA including Senate amendment on hydrocodone abuse; H.R.4215, Medicare Pharmacy Transparency and Fair Auditing Act. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-17T23:25:21.187000-04:00
1305555 FAEGRE BAKER DANIELS CONSULTING aac4dd7a-3556-461c-a652-c160ef240072 Q3 FAEGRE BAKER DANIELS CONSULTING 34158 ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) 2012 third_quarter PHA Online pharmacies - S. 2002 and HR 4095 Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE     0 0 2012-10-18T11:10:34.060000-04:00
1305697 CAPITOLOGIC LLC 49031758-2b8c-4b13-990a-5c20ae296af7 Q3 CAPITOLOGIC LLC 400426045 BULALAW, LLC 2012 third_quarter PHA Federal funding of illegal prescription drug market interventions Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE     0 0 2012-10-18T11:25:25.543000-04:00
1305701 RICCHETTI INCORPORATED 65fbf336-5c9b-4fb7-a72c-300261cc38fc Q3 RICCHETTI INCORPORATED 62778 ELI LILLY AND COMPANY 2012 third_quarter PHA Issues related to pediatric exclusivity policy; Issues related to PDUFA reauthorization. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-18T11:25:53.150000-04:00
1305905 RICCHETTI INCORPORATED 8beb599c-d6ab-4c10-9a51-63002aad5c6f Q3 RICCHETTI INCORPORATED 62778 SANOFI-AVENTIS U S INC 2012 third_quarter PHA Issues related to PDUFA reauthorization. HOUSE OF REPRESENTATIVES,SENATE,U.S. Trade Representative (USTR) 30000   0 0 2012-10-18T11:56:05.127000-04:00
1306052 AMERICAN VETERINARY MEDICAL ASSOCIATION 7f956e1b-9b32-4d01-959b-567ae20a0309 Q3 AMERICAN VETERINARY MEDICAL ASSOCIATION 3630 AMERICAN VETERINARY MEDICAL ASSOCIATION 2012 third_quarter PHA H.R. 965/S. 1211 Preservation of Antibiotics for Medical Treatment Act H.R. 1406 Fairness to Pet Owmers Act DEA regulations impending practice of veterinary medicine; seeking legislative change to underlying statute Agriculture, Dept of (USDA),Defense, Dept of (DOD),Executive Office of the President (EOP),Federal Trade Commission (FTC),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),SENATE   140000 0 0 2012-10-18T12:32:32.133000-04:00
1306066 THE INGRAM GROUP LLC 87d646ee-01e5-495b-9101-bc92e2b773dc Q3 THE INGRAM GROUP LLC 400577737 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) 2012 third_quarter PHA Issues related to pharmaceutical importation and generic drug pricing, S.3187, and the FAIR Generics Act, S.1882. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-10-18T12:34:37.490000-04:00
1306224 GENENTECH, INC f8de7672-23c9-4864-b686-b584fadc5232 Q3 GENENTECH, INC 15920 GENENTECH INC 2012 third_quarter PHA PHA: proposed cuts to Part B reimbursement. 340b reimbursement policy; HOUSE OF REPRESENTATIVES,SENATE   1073000 0 0 2012-10-18T13:08:46.310000-04:00
1306309 ELI LILLY AND COMPANY 5edee2be-f830-4f1f-aaae-b18a9eb3e51e Q3 ELI LILLY AND COMPANY 13392 ELI LILLY AND COMPANY 2012 third_quarter PHA Hospital discounts (HR 3590) Agriculture, Dept of (USDA),Commerce, Dept of (DOC),Food & Drug Administration (FDA),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,State, Dept of (DOS),U.S. Trade Representative (USTR)   3055000 0 0 2012-10-18T13:34:52.153000-04:00
1306335 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 718c1af6-f1c2-4c20-b9d2-cfbba3e438bc Q3 HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) 28776 HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) 2012 third_quarter PHA Rx Pedigree (H.R. 3026/S. 3187); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292/S.3187); Pill Mill Crackdown Act (H.R. 1065/S. 1760/S. 2297); Drug Abuse (S. 507); Drug Shortages (S. 296/ H.R. 2245/H.R. 3839/S. 3187/H.R. 5853/H.R. 5651); Cargo/Product Theft (S. 1002/H.R. 4223); Counterfeit Drugs (S. 1886/H.R. 3668/S. 3187) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   222819 0 0 2012-10-18T13:41:00.287000-04:00
1306682 KNIGHT CAPITOL CONSULTANTS 1d123d37-02e8-4560-b9b8-796b9f9b2574 Q3 KNIGHT CAPITOL CONSULTANTS 40036301 GENZYME CORPORATION 2012 third_quarter PHA S. 606, Creating Hope Act of 2011, S. 296/H.R. 2245, Preserving Access to Life-Saving Medications Act, The Food and Drug Administration Safety and Innovation Act (PL 112-144) and amendments considered, including the Faster Access to Specialized Treatments Act (H.R. 4132) and the Transforming the Regulatory Environment to Accelerate Access to Treatment (TREAT) Act (S. 2113). Assess potential impact of sequestration on public health/food and drug programs. HOUSE OF REPRESENTATIVES,SENATE 30000   0 0 2012-10-18T15:02:14.800000-04:00
1307540 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 5d5a5a32-ce1c-455f-aba4-aef77b5b280b Q3 BAKER DONELSON BEARMAN CALDWELL & BERKOWITZ 5153 THE MEDICINES COMPANY 2012 third_quarter PHA Regulatory and Reimbursement   90000   0 0 2012-10-18T16:41:49.400000-04:00
1307544 MARTIN & SEIBERT, L.C. 77a6d4e2-c34c-49c3-a8d0-6e03afac7430 Q3 MARTIN & SEIBERT, L.C. 400970784 EXPRESS SCRIPTS 2012 third_quarter PHA General education and discussion relating to the tracking of drugs SENATE 20000   0 0 2012-10-18T16:41:50.883000-04:00
1307702 CVS HEALTH (AND SUBSIDIARIES) 8629037f-3a54-4daf-a958-92c7675ff09b Q3 CVS HEALTH (AND SUBSIDIARIES) 302778 CVS CAREMARK INC 2012 third_quarter PHA Issues related to prescription drug abuse, drug supply chain safety and prescriber education. HR 2119 Ryan Creedon Act of 2011 HOUSE OF REPRESENTATIVES,SENATE,White House Office   2320000 0 0 2012-10-18T17:05:58.183000-04:00
1307707 AMERICAN PHARMACISTS ASSOCIATION c450f42e-f91b-4283-8934-011a1e9bb2bb Q3 AMERICAN PHARMACISTS ASSOCIATION 3071 AMERICAN PHARMACISTS ASSOCIATION 2012 third_quarter PHA HCR(PL 111-152/111-148) concerning Medicare PartD;MTM;DME;center for medicare and medicaid innovation;transitions of care;pharmacy reimbursement;agency issues concerning risk evaluation mitigation strategies;PDUFA;prescription drug monitoring program,drug abuse,safe drug supply chain;standardized medication action plans;ACOs;pharmacists role in CMS innovation center initiatives;personalized medication lists; standardized pharmacy notice;immunization;HIT; compounding;medicare part B;SGR;DEA Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE     0 0 2012-10-18T17:06:00.183000-04:00
1308066 BLUESTONE STRATEGIES, LLC 37edd923-024f-404a-8e95-19f48b88fd94 Q3 BLUESTONE STRATEGIES, LLC 400658980 PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) 2012 third_quarter PHA Pharmacy Act; Drug Reimportation; Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-18T18:17:57.800000-04:00
1308434 VAN SCOYOC ASSOCIATES 2d765f65-794d-40fe-83fc-7b7e5c2205d8 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF CONNECTICUT 2012 third_quarter PHA Issues related to FDA salaries and expenses; and extramural research: S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE 40000   0 0 2012-10-19T07:31:35.513000-04:00
1308442 VAN SCOYOC ASSOCIATES 6b3e59cb-6b49-4ff3-a744-5cccbba7d141 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF MARYLAND BALTIMORE 2012 third_quarter PHA S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013, FDA initiatives; and Critical Path initiative. S.3187/H.R.5651, Food and Drug Administration Safety and Innovation Act, FDA initiatives; Critical Path issues. HOUSE OF REPRESENTATIVES,Natl Aeronautics & Space Administration (NASA),SENATE 30000   0 0 2012-10-19T07:31:36.967000-04:00
1308447 VAN SCOYOC ASSOCIATES cccd1cae-30fb-4838-b2ca-6a5b86b37b57 Q3 VAN SCOYOC ASSOCIATES 39837 UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE 2012 third_quarter PHA FDA funding initiatives; Critical Path Partnership. S.2375/H.R.5973, Agriculture,Rural Development,Food and Drug Administration,and Related Agencies Appropriations Act, FY2013 Public Law 112-10, Department of Defense and Full-Year Continuing Appropriations Act, FY2011 Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012 Monitor Prescription Drug User Fee Act (PDUFA) SENATE 40000   0 0 2012-10-19T07:32:38.310000-04:00
1308938 GOVBIZ ADVANTAGE, INC. 39986e36-10d7-4a76-846f-264198d62fa5 Q3 GOVBIZ ADVANTAGE, INC. 294234 CATALYST HEALTH SOLUTIONS (CATAMARANRX) 2012 third_quarter PHA Pharmacy Benefit Issues in health legislation; PBM issues; General company congressional relations; business issues; oversight of PBMs HOUSE OF REPRESENTATIVES,SENATE 50000   0 0 2012-10-19T09:44:54.060000-04:00
1309117 JENCKES AND ASSOCIATES d39236b2-0381-4273-b1c4-eac3b2da26a8 3T JENCKES AND ASSOCIATES 20551 LEO PHARMA INC. 2012 third_quarter PHA Engage FDA, CDC and Hill policy makers on behalf of the client to support regulatory and outreach efforts in the U.S. HOUSE OF REPRESENTATIVES,SENATE     0 1 2012-10-19T10:07:15.487000-04:00
1309155 MR. LORENZ HART 96b767c3-6c8a-4df0-a598-7ebaeed4f3a1 Q3 MR. LORENZ HART 323295 AMERICAN CONSERVATIVE UNION 2012 third_quarter PHA Regulation of pseudoephedrine HOUSE OF REPRESENTATIVES,SENATE 19500   0 0 2012-10-19T10:09:30.093000-04:00
1309180 UNIVERSITY OF CONNECTICUT 9e4fa2b1-c6ae-461e-a9c2-be0e81703341 Q3 UNIVERSITY OF CONNECTICUT 39382 UNIVERSITY OF CONNECTICUT 2012 third_quarter PHA Issues related to FDA salaries and expenses; and extramural research: S.2375/H.R.5973, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, FY2013. Public Law 112-55, Consolidated and Further Continuing Appropriations Act, FY2012. Commerce, Dept of (DOC),HOUSE OF REPRESENTATIVES,SENATE   70000 0 0 2012-10-19T10:12:40.747000-04:00
1309224 AMERICAN ADVERTISING FEDERATION 781831fe-96a3-44a9-b348-4bbd265e2dba Q3 AMERICAN ADVERTISING FEDERATION 1411 AMERICAN ADVERTISING FEDERATION 2012 third_quarter PHA Proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Proposals to require a moratorium on the advertising of new prescription medicines Proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health Oppose proposals to add overly-burdensome product warnings to DTC advertising Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),SENATE   20000 0 0 2012-10-19T10:14:53.850000-04:00
1309466 THE OB-C GROUP, LLC 7d353ee0-4cd0-4419-96cc-121cb3813131 Q3 THE OB-C GROUP, LLC 29802 ELI LILLY 2012 third_quarter PHA No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-19T10:32:36.127000-04:00
1309595 OMNICARE, INC. 11b5535d-3ff8-4727-8f6a-98ef5aa54967 Q3 OMNICARE, INC. 321112 OMNICARE INC 2012 third_quarter PHA HR 4215: Support legislation relating to standardized audit standards for pharmacies with Medicare drug benefit sponsors HOUSE OF REPRESENTATIVES,SENATE   120000 0 0 2012-10-19T10:41:31.133000-04:00
1309606 EMPIRE CONSULTING GROUP a2c7d05f-bb55-42e3-9945-4ba5bed418fa Q3 EMPIRE CONSULTING GROUP 400703105 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA 2012 third_quarter PHA "Dual eligibles" (Medicare-Medicaid) issues; and Medicare Prescription Drug Act issues. HOUSE OF REPRESENTATIVES 30000   0 0 2012-10-19T10:42:36.727000-04:00
1309842 BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC 191bb4bf-1427-49ae-bdd1-83dc4e075044 Q3 BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC 292972 BOEHRINGER INGELHEIM USA CORPORATION 2012 third_quarter PHA Drug Shortages; The Preserving Access to Life Saving Medicines Act (S. 296) Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE   710000 0 0 2012-10-19T11:07:16.370000-04:00
1310174 HAAKE & ASSOCIATES a093a889-68db-4b0c-a81a-95086118cab5 Q3 HAAKE & ASSOCIATES 17226 JOHNSON & JOHNSON SERVICES INC. 2012 third_quarter PHA Policy and procurement matters related to vaccines Army, Dept of (Other),Defense, Dept of (DOD),Defense Logistics Agency,HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,U.S. Marines 20000   0 0 2012-10-19T11:35:38.273000-04:00
1310211 BLUECROSS BLUESHIELD OF TENNESSEE dadae4f8-6fbb-4446-a34f-e89f7b9fa3d5 Q3 BLUECROSS BLUESHIELD OF TENNESSEE 6440 BLUECROSS BLUESHIELD OF TENNESSEE 2012 third_quarter PHA General Pharmacy Issues HOUSE OF REPRESENTATIVES,SENATE   40000 0 0 2012-10-19T11:37:54.097000-04:00
1310295 ARNOLD & PORTER KAYE SCHOLER LLP 40873dd2-8a29-40cd-9a71-01069c73807e Q3 ARNOLD & PORTER KAYE SCHOLER LLP 4301 INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS 2012 third_quarter PHA Issues related to the regulation of the practice of pharmacy compounding. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-19T11:43:31.590000-04:00
1310832 VAN HEUVELEN STRATEGIES, LLC 0f2bddde-3853-46a2-800b-c527e88b8815 Q3 VAN HEUVELEN STRATEGIES, LLC 321874 CVS HEALTH (FORMERLY KNOWN AS CVS CAREMARK) 2012 third_quarter PHA Issues related to prescription drug abuse, drug supply chain safety and prescriber education. H.R.2119, Ryan Creedon Act of 2011 HOUSE OF REPRESENTATIVES,SENATE,White House Office 40000   0 0 2012-10-19T12:41:58.710000-04:00
1310844 RASKY PARTNERS, INC. fccf8236-0be6-459a-a3d9-005cc4db26de Q3 RASKY PARTNERS, INC. 297410 ELI LILLY AND CO 2012 third_quarter PHA Monitor biologics related issues, Medicare Part D HOUSE OF REPRESENTATIVES,SENATE 22500   0 0 2012-10-19T12:44:03.067000-04:00
1310955 VAN HEUVELEN STRATEGIES, LLC d1c5718d-49ba-4501-a66b-20136de91374 Q3 VAN HEUVELEN STRATEGIES, LLC 321874 DAVITA 2012 third_quarter PHA Provisions pertaining to kidney care, dialysis, Medicare, Medicaid, CMS reimbursement issues, and health insurance. Implementation of Patient Protection and Affordable Care Act. Implementation of the Budget Control Act. HOUSE OF REPRESENTATIVES,SENATE 60000   0 0 2012-10-19T12:58:48.470000-04:00
1311001 COVIDIEN LP c1c55f8a-bdd5-4d44-ac98-0994b12da21d Q3 COVIDIEN LP 319778 COVIDIEN LP 2012 third_quarter PHA Issues involving controlled substance and pain and addiction drugs generally; H.R. 2119: Ryan Creedon Act of 2011To amend the Controlled Substances Act to require practitioners to obtain particular training or special certification, approved by the Attorney General, on addiction to and abuse of controlled substances and appropriate and safe use of controlled substances in schedule II, III, IV, or V, and for other purposes; Issues related to acetaminophen. Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE   460000 0 0 2012-10-19T13:01:59.903000-04:00
1311087 MCDERMOTT WILL & SCHULTE LLP 5cb29314-4cb9-40a8-9d19-91c0a9efd2a0 Q3 MCDERMOTT WILL & SCHULTE LLP 24338 RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION 2012 third_quarter PHA Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE 130000   0 0 2012-10-19T13:14:36.843000-04:00
1311368 AMERICAN OPTOMETRIC ASSOCIATION d7631098-80b3-4d0f-a939-5b022999066d Q3 AMERICAN OPTOMETRIC ASSOCIATION 2981 AMERICAN OPTOMETRIC ASSOCIATION 2012 third_quarter PHA S 2297, A bill to amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug, all sections relating to vision. HOUSE OF REPRESENTATIVES,SENATE   100000 0 0 2012-10-19T13:47:26.757000-04:00
1311396 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 64d25597-5d37-4057-a8f4-2fd1328132db Q3 AMERICA'S HEALTH INSURANCE PLANS, INC. (AHIP) 1581 AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) 2012 third_quarter PHA H.R. 979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act (Lynch) FEHBP prescription drugs 16. Specific Lobbying Issues (continued): H.R.1946, Preserving Hometown Independent Pharmacies Act (Marino) antitrust exemption for independent pharmacies H.R. 3995, Protecting Consumer Access to Generic Drugs Act (Rush) pay-for-delay settlements S. 27, Preserve Access to Affordable Generics Act (Kohl) pay-for-delay settlements S. 2002, Online Pharmacy Safety Act (Feinstein) establishes standards for on-line pharmacies S. 2193, Ensuring Safe Medical Devices for Patients (Merkley) FDA oversight of medical devices S. 3187, the FDA Safety and Innovation Act (Harkin) pharmaceutical, medical device issues Regulatory Issues: Issues relating to long term safety and effectiveness of medical devices and drugs, including registries; issues relating to post-market surveillance of drugs and medical devices; issues relating to access for investigational drugs; and other issues relating to health care reform implementation. Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Federal Bureau of Investigation (FBI),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),Labor, Dept of (DOL),Medicare Payment Advisory Commission (MedPAC),Office of Management & Budget (OMB),Office of Personnel Management (OPM),Pension & Welfare Benefits Administration,SENATE,Treasury, Dept of,White House Office   2630000 0 0 2012-10-19T13:49:38.160000-04:00
1311639 340B HEALTH cd8032b6-ed4e-4017-a0d3-3bad5b7cc506 Q3 340B HEALTH 316434 340B HEALTH 2012 third_quarter PHA Discussing the importance of the 340B drug discount program and improving program oversight. Advocating for extension of program to the inpatient setting and repeal of the orphan drug ban. HOUSE OF REPRESENTATIVES,Natl Economic Council (NEC),SENATE,White House Office   235879 0 0 2012-10-19T14:14:17.473000-04:00
1311694 COMPASS CONSULTING GROUP, LLC 3b1df5bd-6552-4e40-9fcb-6d0c4067ac6c Q3 COMPASS CONSULTING GROUP, LLC 295031 AMYLIN PHARMACEUTICALS, INC. 2012 third_quarter PHA General FDA, pharmaceutical, and Medicare issues. HOUSE OF REPRESENTATIVES,SENATE 20000   0 0 2012-10-19T14:17:41.313000-04:00
1312013 NATIONAL RURAL HEALTH ASSOCATION 42d8feb6-58ca-4378-a432-342d35b43475 Q3 NATIONAL RURAL HEALTH ASSOCATION 53048 NATIONAL RURAL HEALTH ASSOCATION 2012 third_quarter PHA Support for 340B drug program. Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE   25222 0 0 2012-10-19T14:35:49.997000-04:00

Next page

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE lobbying_activities (
            id INTEGER PRIMARY KEY,
            filing_uuid TEXT NOT NULL,
            filing_type TEXT NOT NULL,
            registrant_name TEXT NOT NULL,
            registrant_id INTEGER,
            client_name TEXT NOT NULL,
            filing_year INTEGER NOT NULL,
            filing_period TEXT NOT NULL,
            issue_code TEXT,
            specific_issues TEXT,
            government_entities TEXT,
            income_amount INTEGER,
            expense_amount INTEGER,
            is_no_activity INTEGER DEFAULT 0,
            is_termination INTEGER DEFAULT 0,
            received_date TEXT,
            CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
                REFERENCES lobbying_filings_raw(filing_uuid)
        );
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);
Powered by Datasette · Queries took 1550.128ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API